Literature DB >> 18482723

Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury.

Janette M Krum1, Nina Mani, Jeffrey M Rosenstein.   

Abstract

Following trauma to the brain significant changes occur in both the astroglial and vascular components of the neuropil. Angiogenesis is required to re-establish metabolic support and astrocyte activation encompasses several functions including scar formation and the production of growth factors. VEGF has seminal involvement in the process of brain repair and is upregulated during many pathological events. VEGF signaling is regulated mainly through its two primary receptors: flk-1 (KDR/VEGF-R2) is expressed on vascular endothelium and some neurons and flt-1 (VEGF-R1) in the CNS, is expressed predominantly by activated astrocytes. Using an injury model of chronic minipump infusion of neutralizing antibodies (NA) to block VEGF receptor signaling, this study takes advantage of these differences in VEGF receptor distribution in order to understand the role the cytokine plays after brain injury. Infusion of NA to flk-1 caused a significant decrease in vascular proliferation and increased endothelial cell degeneration compared to control IgG infusions but had no effect on astrogliosis. By contrast infusion of NA to flt-1 significantly decreased astroglial mitogenicity and scar formation and caused some increase in endothelial degeneration. Neutralization of the flt-1 receptor function, but not flk-1, caused significant reduction in the astroglial expression of the growth factors, CNTF and FGF by 7days. These data suggest that after CNS injury, endogenous VEGF upregulation (by astrocytes) induces angiogenesis and, by autocrine signaling, increases both astrocyte proliferation and facilitates expression of growth factors. It is likely that VEGF plays an important role in aspects of astroglial scar formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482723      PMCID: PMC2478519          DOI: 10.1016/j.expneurol.2008.03.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  100 in total

1.  Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain.

Authors:  K L Jin; X O Mao; T Nagayama; P C Goldsmith; D A Greenberg
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration.

Authors:  M Sköld; S Cullheim; H Hammarberg; F Piehl; A Suneson; S Lake; A Sjögren; E Walum; M Risling
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

3.  Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain.

Authors:  P Pichiule; J C Chávez; K Xu; J C LaManna
Journal:  Brain Res Mol Brain Res       Date:  1999-12-10

4.  Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds.

Authors:  J M Krum; J M Rosenstein
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

5.  Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal.

Authors:  K L Jin; X O Mao; D A Greenberg
Journal:  J Mol Neurosci       Date:  2000-06       Impact factor: 3.444

6.  Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms.

Authors:  D G Fujikawa; S S Shinmei; B Cai
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 7.  The ciliary neurotrophic factor and its receptor, CNTFR alpha.

Authors:  M W Sleeman; K D Anderson; P D Lambert; G D Yancopoulos; S J Wiegand
Journal:  Pharm Acta Helv       Date:  2000-03

8.  Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.

Authors:  K L Jin; X O Mao; D A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown.

Authors:  M N Tsao; Y Q Li; G Lu; Y Xu; C S Wong
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

10.  The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model.

Authors:  Takao Yasuhara; Tetsuro Shingo; Kenichiro Muraoka; Yuan wen Ji; Masahiro Kameda; Akira Takeuchi; Akimasa Yano; Shinsaku Nishio; Toshihiro Matsui; Yasuyuki Miyoshi; Hirofumi Hamada; Isao Date
Journal:  Brain Res       Date:  2005-03-15       Impact factor: 3.252

View more
  39 in total

1.  Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.

Authors:  Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2015-12-11       Impact factor: 4.939

Review 2.  The stem cell potential of glia: lessons from reactive gliosis.

Authors:  Stefanie Robel; Benedikt Berninger; Magdalena Götz
Journal:  Nat Rev Neurosci       Date:  2011-02       Impact factor: 34.870

3.  The HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia model.

Authors:  Jong-In Na; Joo-Young Na; Woo-Young Choi; Min-Cheol Lee; Man-Seok Park; Kang-Ho Choi; Jeong-Kil Lee; Kyung-Tae Kim; Jong-Tae Park; Hyung-Seok Kim
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

4.  VEGF induces neuroglial differentiation in bone marrow-derived stem cells and promotes microglia conversion following mobilization with GM-CSF.

Authors:  Bat-Chen R Avraham-Lubin; Nitza Goldenberg-Cohen; Tamilla Sadikov; Nadir Askenasy
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 5.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Glutamate Neonatal Excitotoxicity Modifies VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 Protein Expression Profiles During Postnatal Development of the Cerebral Cortex and Hippocampus of Male Rats.

Authors:  Jose Luis Castañeda-Cabral; Carlos Beas-Zarate; Graciela Gudiño-Cabrera; Monica E Ureña-Guerrero
Journal:  J Mol Neurosci       Date:  2017-07-29       Impact factor: 3.444

7.  CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Authors:  Georgette L Suidan; Jonathan W Dickerson; Yi Chen; Jeremiah R McDole; Pulak Tripathi; Istvan Pirko; Kim B Seroogy; Aaron J Johnson
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

8.  Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery.

Authors:  Richard L Benton; Melissa A Maddie; Mark J Gruenthal; Theo Hagg; Scott R Whittemore
Journal:  Curr Neurovasc Res       Date:  2009-05       Impact factor: 1.990

9.  Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.

Authors:  Lei Liu; Masashi Fujimoto; Fumihiro Kawakita; Fumi Nakano; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

10.  Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes.

Authors:  Nicole A Renner; Hope A Sansing; Fiona M Inglis; Smriti Mehra; Deepak Kaushal; Andrew A Lackner; Andrew G Maclean
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.